UBS Group’s Stantec STN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.1M Sell
203,961
-103,428
-34% -$8.34M ﹤0.01% 3064
2026
Q1
$26.6M Sell
307,389
-83,255
-21% -$7.83M ﹤0.01% 2289
2025
Q4
$36.9M Buy
390,644
+73,539
+23% +$7.57M 0.01% 1963
2025
Q3
$34.2M Buy
317,105
+131,338
+71% +$14.3M 0.01% 2011
2025
Q2
$20.2M Buy
185,767
+51,183
+38% +$4.93M ﹤0.01% 2347
2025
Q1
$11.1M Sell
134,584
-35,591
-21% -$2.85M ﹤0.01% 2919
2024
Q4
$13.4M Buy
170,175
+25,422
+18% +$2.11M ﹤0.01% 2742
2024
Q3
$11.6M Buy
144,753
+36,109
+33% +$2.99M ﹤0.01% 2230
2024
Q2
$9.08M Buy
108,644
+19,643
+22% +$1.6M ﹤0.01% 2289
2024
Q1
$7.39M Buy
89,001
+42,780
+93% +$3.52M ﹤0.01% 2558
2023
Q4
$3.71M Buy
46,221
+13,246
+40% +$919K ﹤0.01% 3096
2023
Q3
$2.14M Sell
32,975
-37,345
-53% -$2.48M ﹤0.01% 3378
2023
Q2
$4.59M Sell
70,320
-27,234
-28% -$1.64M ﹤0.01% 2675
2023
Q1
$5.7M Sell
97,554
-26,392
-21% -$1.43M ﹤0.01% 2392
2022
Q4
$5.94M Buy
123,946
+27,650
+29% +$1.33M ﹤0.01% 2333
2022
Q3
$4.22M Buy
96,296
+13,952
+17% +$657K ﹤0.01% 2510
2022
Q2
$3.61M Sell
82,344
-90
-0.1% -$4.12K ﹤0.01% 2649
2022
Q1
$4.13M Sell
82,434
-5,802
-7% -$301K ﹤0.01% 2725
2021
Q4
$4.96M Buy
88,236
+15,697
+22% +$848K ﹤0.01% 2826
2021
Q3
$3.4M Buy
72,539
+24,589
+51% +$1.16M ﹤0.01% 3093
2021
Q2
$2.14M Buy
47,950
+644
+1% +$29K ﹤0.01% 3517
2021
Q1
$2.02M Sell
47,306
-39,516
-46% -$1.52M ﹤0.01% 3559
2020
Q4
$2.82M Buy
86,822
+4,227
+5% +$130K ﹤0.01% 3047
2020
Q3
$2.51M Sell
82,595
-280
-0.3% -$8.87K ﹤0.01% 2845
2020
Q2
$2.56M Buy
82,875
+67,700
+446% +$1.98M ﹤0.01% 2649
2020
Q1
$388K Sell
15,175
-3,048
-17% -$87.8K ﹤0.01% 4187
2019
Q4
$516K Buy
18,223
+2,120
+13% +$52.4K ﹤0.01% 4811
2019
Q3
$357K Sell
16,103
-5,608
-26% -$128K ﹤0.01% 4820
2019
Q2
$520K Sell
21,711
-323
-1% -$7.79K ﹤0.01% 4272
2019
Q1
$521K Buy
22,034
+4,677
+27% +$111K ﹤0.01% 4037
2018
Q4
$380K Sell
17,357
-3,881
-18% -$93.3K ﹤0.01% 4468
2018
Q3
$528K Buy
21,238
+681
+3% +$17.4K ﹤0.01% 4359
2018
Q2
$527K Buy
20,557
+1,977
+11% +$50.1K ﹤0.01% 4281
2018
Q1
$458K Sell
18,580
-155
-0.8% -$4.18K ﹤0.01% 4270
2017
Q4
$523K Sell
18,735
-5,332
-22% -$149K ﹤0.01% 4259
2017
Q3
$668K Buy
24,067
+701
+3% +$18.6K ﹤0.01% 4004
2017
Q2
$587K Sell
23,366
-10
-0% -$246 ﹤0.01% 4011
2017
Q1
$605K Sell
23,376
-11,589
-33% -$304K ﹤0.01% 3908
2016
Q4
$883K Sell
34,965
-49,899
-59% -$1.23M ﹤0.01% 3651
2016
Q3
$2M Buy
84,864
+17,889
+27% +$429K ﹤0.01% 2847
2016
Q2
$1.62M Sell
66,975
-7,086
-10% -$180K ﹤0.01% 2947
2016
Q1
$1.88M Buy
74,061
+55,611
+301% +$1.28M ﹤0.01% 2726
2015
Q4
$457K Buy
18,450
+7,531
+69% +$188K ﹤0.01% 4029
2015
Q3
$239K Sell
10,919
-64,630
-86% -$1.64M ﹤0.01% 4490
2015
Q2
$2.21M Sell
75,549
-172,043
-69% -$4.72M ﹤0.01% 2876
2015
Q1
$5.92M Buy
247,592
+20,295
+9% +$514K ﹤0.01% 1925
2014
Q4
$6.23M Buy
+227,297
New +$6.75M ﹤0.01% 1894

Other funds holding STN

UBS Group's STN Position: Q2 2026 in Review

UBS Group reduced its Stantec (STN) stake by 34% in Q2 2026, selling an estimated $8.34M and leaving 203,961 shares worth $14.1M. The position accounts for ﹤0.01% of the portfolio, ranked #3064.

UBS Group first reported a position in STN in Q4 2014 and has held it in 47 quarters since. The position peaked at $36.9M in Q4 2025. 291 funds tracked by Wall St. Rank hold STN as of Q2 2026.

  • UBS Group held 203,961 shares of Stantec worth $14.1M as of Q2 2026.
  • UBS Group sold 103,428 Stantec shares in Q2 2026, an estimated $8.34M.
  • Stantec made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #3064 holding.
  • UBS Group first reported a position in Stantec in Q4 2014 and has held it in 47 quarters since.
  • UBS Group's Stantec position peaked at $36.9M in Q4 2025.
  • 291 funds tracked by Wall St. Rank held Stantec as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.